Axon Enterprise, Inc $AXON Shares Purchased by CVA Family Office LLC

CVA Family Office LLC raised its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 26.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 66 shares of the biotechnology company’s stock after buying an additional 14 shares during the quarter. CVA Family Office LLC’s holdings in Axon Enterprise were worth $55,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in AXON. LaSalle St. Investment Advisors LLC boosted its stake in shares of Axon Enterprise by 2.1% during the first quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company’s stock valued at $408,000 after acquiring an additional 16 shares during the last quarter. Hemington Wealth Management lifted its holdings in Axon Enterprise by 70.8% in the 2nd quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 17 shares in the last quarter. Washington Trust Advisors Inc. boosted its stake in shares of Axon Enterprise by 44.7% during the 2nd quarter. Washington Trust Advisors Inc. now owns 55 shares of the biotechnology company’s stock worth $46,000 after purchasing an additional 17 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in shares of Axon Enterprise by 5.0% during the first quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company’s stock worth $203,000 after buying an additional 18 shares in the last quarter. Finally, WCM Investment Management LLC raised its position in shares of Axon Enterprise by 0.8% in the first quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company’s stock valued at $1,306,000 after buying an additional 19 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts recently issued reports on AXON shares. Wolfe Research started coverage on shares of Axon Enterprise in a research report on Monday, July 7th. They set an “outperform” rating on the stock. UBS Group restated a “neutral” rating and set a $840.00 price objective (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Northland Securities set a $800.00 target price on Axon Enterprise in a research note on Tuesday, August 5th. Craig Hallum raised Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price target on the stock in a research note on Tuesday, August 5th. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $855.00 price objective (up previously from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $841.64.

Insider Activity

In related news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, August 11th. The shares were sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the transaction, the chief executive officer owned 3,053,982 shares in the company, valued at approximately $2,538,744,696.78. The trade was a 0.33% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Brittany Bagley sold 5,000 shares of the company’s stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total transaction of $3,569,400.00. Following the sale, the chief financial officer directly owned 93,592 shares of the company’s stock, valued at approximately $66,813,456.96. This trade represents a 5.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 59,932 shares of company stock valued at $45,115,616 over the last quarter. 5.70% of the stock is owned by insiders.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $735.95 on Monday. Axon Enterprise, Inc has a twelve month low of $422.38 and a twelve month high of $885.91. The stock has a market capitalization of $57.77 billion, a P/E ratio of 181.72, a PEG ratio of 28.58 and a beta of 1.41. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The business’s fifty day moving average price is $733.17 and its 200 day moving average price is $726.44.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping the consensus estimate of $1.54 by $0.58. The company had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm’s revenue was up 32.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, research analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.